Workflow
化学原料及化学制品制造业
icon
Search documents
合盛硅业1月12日现1笔大宗交易 总成交金额3143.25万元 溢价率为-9.74%
Xin Lang Zheng Quan· 2026-01-12 10:20
进一步统计,近3个月内该股累计发生15笔大宗交易,合计成交金额为7.66亿元。该股近5个交易日累计 上涨2.12%,主力资金合计净流出1.35亿元。 1月12日,合盛硅业收跌0.29%,收盘价为54.84元,发生1笔大宗交易,合计成交量63.5万股,成交金额 3143.25万元。 第1笔成交价格为49.50元,成交63.50万股,成交金额3,143.25万元,溢价率为-9.74%,买方营业部为财 通证券股份有限公司慈溪文华南路证券营业部,卖方营业部为财通证券股份有限公司慈溪文华南路证券 营业部。 责任编辑:小浪快报 ...
亚星化学1月12日龙虎榜数据
亚星化学(600319)今日下跌6.93%,全天换手率4.94%,成交额1.61亿元,振幅8.50%。龙虎榜数据显 示,营业部席位合计净卖出1074.80万元。 上交所公开信息显示,当日该股因日跌幅偏离值达-8.02%上榜,营业部席位合计净卖出1074.80万元。 亚星化学1月12日交易公开信息 | 买/ | 会员营业部名称 | 买入金额(万 | 卖出金额(万 | | --- | --- | --- | --- | | 卖 | | 元) | 元) | | 买一 | 浙商证券股份有限公司北京朝阳门北大街证券营业部 | 1200.84 | | | 买二 | 中国银河证券股份有限公司湛江海北路证券营业部 | 563.34 | | | 买三 | 高盛(中国)证券有限责任公司上海浦东新区世纪大道证券 营业部 | 253.86 | | | 买四 | 德邦证券股份有限公司上海福山路证券营业部 | 249.52 | | | 买五 | 国泰海通证券股份有限公司总部 | 224.40 | | | 卖一 | 国泰海通证券股份有限公司深圳深南大道京基一百证券营 | | 1690.26 | | | 业部 | | | | 卖二 | 国泰 ...
闰土股份:公司拟于2026年4月29日披露《2025年年度报告》
Mei Ri Jing Ji Xin Wen· 2026-01-12 09:00
Group 1 - The company, Runtou Co., Ltd. (002440.SZ), responded to an investor inquiry regarding the number of shareholders as of December 31, 2025, indicating that this information will be disclosed in the annual report scheduled for April 29, 2026 [2]
长联科技控股子公司1500万元项目环评获同意
Mei Ri Jing Ji Xin Wen· 2026-01-12 09:00
Core Insights - The core viewpoint of the article highlights that Changlian Technology (301618) has received approval for an environmental assessment of its subsidiary, Huizhou Changlian New Materials Technology Co., Ltd., for a project aimed at producing 50,000 tons of eco-friendly water-based printing glue, water-based acrylic resin, and silicone oil, with a total investment of 15 million yuan [1]. Group 1: Company Developments - Changlian Technology's subsidiary has received approval for an environmental assessment for a project with a total investment of 15 million yuan [1]. - The project will focus on producing 50,000 tons of environmentally friendly materials, indicating a commitment to sustainable practices [1]. Group 2: Industry Context - The "A-share Green Report" project aims to enhance transparency in environmental information for listed companies, collaborating with the public environmental research center (IPE) [1]. - The project monitors environmental performance based on authoritative regulatory data from 31 provinces and 337 cities, providing insights into the environmental risks associated with listed companies [1].
兴发集团(600141.SH):2025年公司对外供应黑磷产品近200公斤,同比增长超210%
Ge Long Hui· 2026-01-12 08:39
格隆汇1月12日丨兴发集团(600141.SH)在互动平台表示,产业化方面,公司黑磷制备技术已实现百公斤 级连续化稳定生产,百吨级生产线具备快速建成能力,同时产品制造成本显著下降,从经济性角度已具 备商业化条件。应用研发方面,基于当前高质量、低成本的黑磷制备能力,公司前瞻布局未来潜力巨大 的应用领域,合作科研机构及企业数量从2024年末的30余家扩大至2025年末近90家。近期公司与合作伙 伴在航天材料领域取得重大科研成果,将黑磷下游应用领域从磷碳负极材料、光电子芯片、生物医药和 催化剂等领域进一步扩大。商业应用方面,黑磷-钯催化剂已在兴瑞公司双氧水生产中实现工业化应 用,氢效最高提升近20%;黑磷净味催化剂已通过美的集团企业标准认证,标志着相关技术产业化与市 场应用取得重要进展。2025年公司对外供应黑磷产品近200公斤,同比增长超210%。 ...
鲁北化工:控股股东4000万股解除质押,剩余质押5000万股
Xin Lang Cai Jing· 2026-01-12 08:37
Core Viewpoint - The announcement indicates that the controlling shareholder, Luban Group, will release a pledge of 40 million unrestricted circulating shares to Zhongtai Securities on January 9, 2026, which represents 22.10% of its holdings and 7.57% of the total share capital [1] Group 1 - Luban Group currently holds 181 million shares, accounting for 34.24% of the total share capital [1] - After the release of the pledge, Luban Group will have a total of 50 million shares pledged, which is 27.63% of its holdings and 9.46% of the total share capital [1] - The released shares will be used for subsequent pledge financing, and there are currently no risks of forced liquidation or transfer [1]
维远股份2025预亏 上市超募20亿中信证券中泰证券保荐
Zhong Guo Jing Ji Wang· 2026-01-12 08:15
Group 1 - The core point of the article is that Weiyuan Co., Ltd. (维远股份) has announced that its performance for 2025 is expected to be below expectations due to factors such as declining product prices, leading to a projected net loss for the year [1] - Weiyuan Co., Ltd. was listed on the Shanghai Stock Exchange on September 15, 2021, with an initial public offering of 138 million shares at a price of 29.56 yuan per share, and the stock is currently trading below its initial offering price [1] - The total amount raised from the initial public offering was 4.065 billion yuan, with a net amount of 3.88 billion yuan after deducting issuance costs, which was 2 billion yuan more than originally planned [1] Group 2 - In 2024, Weiyuan Co., Ltd. achieved an operating revenue of 9.522 billion yuan, representing a year-on-year increase of 35.06%, while the net profit attributable to shareholders decreased by 42.62% to 56.59 million yuan [2] - The company's net profit after deducting non-recurring gains and losses was 45.31 million yuan, down 36.85% year-on-year, while the net cash flow from operating activities increased by 49.52% to 918 million yuan [2]
PVC报告2026年1月:探底回升,宽幅震荡
Hong Ye Qi Huo· 2026-01-12 06:44
研究报告 – PVC 报告 2026 年 1 月 金融研究院 探底回升,宽幅震荡 摘要 2025 年 PVC 市场在国内需求收缩—供给缓慢扩张—出口被动放量—库存 高位钝化—成本中枢下移这一链条中反复寻找均衡点。 今年突出的变化有三点:一个是外需权重显著提升,出口在内需疲弱时承 担了"逆周期稳定器"的角色。二是产能扩张的工艺与区域结构变化,新增产 能更多来自沿海乙烯法及一体化装置,这改变了行业成本曲线的形态与边际供 给弹性。其三,库存从'高位但可消化'转向'高位且黏性'——库存的季节 性波动仍在,但其对价格的边际解释力被出口与成本所部分稀释,交易逻辑更 强调"库存变化率"而非库存绝对水平。 展望 2026 年:价格中枢难以脱离弱内需、强外需、供给弹性收敛这三因 素博弈。我们建议以"供给弹性—需求弹性—贸易弹性"的三维框架来组织交 易与风险管理:供给弹性取决于新增产能兑现、装置检修与环保约束;需求弹 性取决于地产链修复速度以及基建、制造业对冲能力;贸易弹性取决于印度等 关键市场的政策与新增产能节奏。在此框架下,策略上宜更偏向"区间+事件 驱动",并以基差、月差与跨品种成本逻辑来构建组合。 一、行情回顾 2025 ...
A股异动 | 和邦生物放量跌逾5%,2025年度业绩预亏
Ge Long Hui A P P· 2026-01-12 05:58
Core Viewpoint - Hebang Biotechnology (603077.SH) experienced a significant drop of 5.15% in stock price, closing at 2.21 yuan, following the announcement of expected losses for the fiscal year 2025 due to asset impairment provisions [1] Financial Performance - The company anticipates a net profit loss for the fiscal year 2025, primarily attributed to the need for asset impairment provisions [1] - The total market capitalization of Hebang Biotechnology is reported at 19.52 billion yuan [1] - The trading volume exceeded 800 million yuan on the day of the announcement [1] Future Actions - Hebang Biotechnology will adhere to relevant regulations and expedite financial accounting and asset impairment testing to promptly disclose the asset impairment provision announcement and the 2025 performance forecast [1] - The data related to the asset impairment provision will be based on figures recognized by the company's auditing agency and confirmed by the board of directors [1] - The official financial data for 2025 will be disclosed in the audited annual report [1]
鲁西化工(000830) - 2026年1月9日投资者关系活动记录表
2026-01-12 00:26
| | ☑特定对象调研 □分析师会议 | | --- | --- | | | □媒体采访 业绩说明会 | | 投资者关系活动类别 | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 | | 活动参与人员 | 汇添富基金:刘高晓、高田昊等 | | | 申万宏源证券:邵靖宇、陈陶 | | 时间 | 2026 年 1 月 9 日 | | 地点 | 公司会议室 | | 形式 | 现场交流 | | 上市公司接待人员 | 董事会秘书 刘月刚 | | 姓名 | 证券事务代表 柳青 | | | 互动沟通主要内容如下: 一、介绍公司近期生产经营情况 | | | 近期园区整体生产经营情况正常,公司继续加强生产企业的冬季 安全管控,大力度开展节能降耗、提质增效,规避市场风险,紧跟相 | | | 关政策及行业发展动态,结合公司实际情况动态调整,统筹分析预判 | | | 市场变化,及时调整生产经营策略,发挥园区一体化优势,力争把握 | | 交流内容及具体问答 记录 | 市场机遇,实现经济效益最大化。 | | | 二、沟通了解 2025 年四季度产品市场变化情况 | | | 第四季度,受同行企业及下游企业开工率波 ...